日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antipsychotic-like effect of the muscarinic acetylcholine receptor agonist BuTAC in non-human primates

毒蕈碱乙酰胆碱受体激动剂丁酰亚胺(BuTAC)在非人灵长类动物中表现出抗精神病样作用

Andersen, Maibritt B; Croy, Carrie Hughes; Dencker, Ditte; Werge, Thomas; Bymaster, Frank P; Felder, Christian C; Fink-Jensen, Anders

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

对阿托莫西汀滥用潜力评估的综述:一种用于治疗注意力缺陷/多动障碍的非兴奋剂药物

Upadhyaya, Himanshu P; Desaiah, Durisala; Schuh, Kory J; Bymaster, Frank P; Kallman, Mary J; Clarke, David O; Durell, Todd M; Trzepacz, Paula T; Calligaro, David O; Nisenbaum, Eric S; Emmerson, Paul J; Schuh, Leslie M; Bickel, Warren K; Allen, Albert J

Antipsychotic-induced gene regulation in multiple brain regions

抗精神病药物诱导的多个脑区基因调控

Girgenti, Matthew James; Nisenbaum, Laura K; Bymaster, Franklin; Terwilliger, Rosemarie; Duman, Ronald S; Newton, Samuel Sathyanesan

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection

抗精神病药物:动物模型中疗效、神经递质调节和神经保护作用的比较

Lieberman, Jeffrey A; Bymaster, Frank P; Meltzer, Herbert Y; Deutch, Ariel Y; Duncan, Gary E; Marx, Christine E; Aprille, June R; Dwyer, Donard S; Li, Xin-Min; Mahadik, Sahebarao P; Duman, Ronald S; Porter, Joseph H; Modica-Napolitano, Josephine S; Newton, Samuel S; Csernansky, John G

Abstracts from the ASENT 2006 Annual Meeting March 8–11, 2006

ASENT 2006年年会摘要(2006年3月8日至11日)

Jiruska, Premysl; de Curtis, Marco; Jefferys, John G R; Schevon, Catherine A; Schiff, Steven J; Schindler, Kaspar; Pritchett, Y; McCarberg, B; Watkin, J; Chappell, A; Robinson, M; Xu, J; Rotz, B; Wernicke, J; Detke, M; Iyengar, S; Henck, J; Bymaster, F; Callaghan, J; Knadler, M; Thase, M; Meratee, M; Chung, J; Schweitzer, J; Byrnes, K; Stoica, B; Di Giovanni, S; De Biase, A; Knoblach, S; Hoffman, E; Faden, A; Michaeli, S; Sorce, D; Öz, G; Ugurbil, K; Garwood, M; Tuite, P; Jett, D; Deberdt, W; Csernansky, J; Buckley, P; Peiskens, J; Lipkovich, I; Kollack-Walter, S; Houston, J; Zhang, Y; Liu-Siefert, H; Buckley, P F; Csernansky, J G; Peuskens, J; Kollack-Walker, S; Houston, J P; Rotelli, M; Theodore, W; Giovacchini, G; Bagic, A; Herscovitch, P; Carson, R; Herholz, K; Weisenbach, S; Hilker, R; Heiss, W; Nahab, F; Hallett, M; El-Khodor, B; Edgar, N; Chen, A; Heyes, M P; Jiang, Q; Ahmed, S; Pedersen, R; Musgnung, J; Entsuah, R; Nordberg, A; Masdeu, J; Gerhard, A; Ebmeier, K; Pappata, S; Perani, D; van Laere, K; Halldin, C; Salmon, E; Knudsen, G; Robins, S; Fehlings, M; Baptiste, D; Skolnick, B E; Davis, S M; Bran, N C; Mathew, S E; Mayer, S A; Kaminski, R M; Marini, H; Ortinski, P I; Yonekawa, W; Vicini, S; Rogawski, M A; Gasior, M; Tang, R; White, N

The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

CB1受体拮抗剂SR141716A选择性地增强内侧前额叶皮层的单胺能神经传递:对治疗作用的启示

Tzavara, Eleni T; Davis, Richard J; Perry, Kenneth W; Li, Xia; Salhoff, Craig; Bymaster, Frank P; Witkin, Jeffrey M; Nomikos, George G

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

米诺环素可预防MPTP诱导的帕金森病模型中黑质纹状体多巴胺能神经退行性变

Du, Y; Ma, Z; Lin, S; Dodel, R C; Gao, F; Bales, K R; Triarhou, L C; Chernet, E; Perry, K W; Nelson, D L; Luecke, S; Phebus, L A; Bymaster, F P; Paul, S M